Company Announcements

Donate five million doses of BNT162b2 vaccine

Source: RNS
RNS Number : 8403E
Hon Hai Precision Industry Co Ld
11 July 2021
 

Subject: Hon Hai &YongLin Foundation jointly donate five million (5,000,000) doses of BNT162b2 vaccine to Taiwan CDC for use to fight off the COVID-19 pandemic

Contents:

1.   Date of occurrence of the event: 2021/07/11

2.   Reason for the donation: Hon Hai &YongLin Foundation jointly donate five million (5,000,000) doses of BNT162b2 vaccinefor use to fight off the COVID-19 pandemic.

3.   Total amount of the donation: The approximate value will not exceed USD$175,000,000 (including the vaccine procurement, the necessary cold-chain logistics and handling services, and the insurance).Hon Hai will not exceedUS$105,000,000 and YongLin Foundation will not exceed US$70,000,000.

4.   Counterparty to the donation: Taiwan Centers for Disease Control,Ministry of Health and Welfare, Executive Yuan.

5.   Relationship with the Company: none.

6.   Name and resume of independent director(s) that expressed an objection or qualified opinion: NA.

7.   Objection or qualified opinion by the aforementioned independent director(s): NA.

8.   Any other matters that need to be specified: This donation is an emergency donation made for the public welfare for material disasters relief. This donation will be proposed to Hon Hai's Board Meeting for the Board's ratification.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCLFLLFFDLEBBX